What is the incidence and risk factors for perforation during endoscopic retrograde cholangiopancreatography (ERCP), how is a suspected perforation identified and managed acutely, and how can the risk be minimized?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Risk of Perforation in ERCP

ERCP-related perforation occurs in 0.14-1.6% of procedures but carries a mortality rate of 7.8-9.9%, with delayed diagnosis beyond 6 hours dramatically increasing mortality, making early recognition and aggressive management critical to survival. 1, 2, 3

Incidence and Mortality

  • The overall perforation rate during ERCP ranges from 0.14% to 1.6%, with most contemporary series reporting rates around 0.45-0.9% 1, 2, 4, 5

  • Mortality from ERCP-related perforation is substantial at 7.8-9.9%, with some series reporting rates as high as 20% when including 90-day mortality 1, 6

  • Delayed recognition beyond 6 hours is the single most important modifiable factor associated with increased mortality, prolonged hospital stay, and need for more complex surgical intervention 1, 7, 2

Classification of ERCP Perforations

Type 1 (Lateral Duodenal Wall Perforation):

  • Caused by excessive shearing force or angle-related trauma from the duodenoscope shaft or tip 1
  • Results in intraperitoneal or retroperitoneal leakage of bowel contents 1
  • Characterized by sudden bleeding, lumen deflation, and difficulty maintaining insufflation 1
  • Large perforations >3 cm are difficult to close endoscopically and require urgent surgical consultation 8

Type 2 (Periampullary/Retroperitoneal Perforation):

  • Caused by overextension of sphincterotomy beyond the intraduodenal portion of the ampulla 1
  • These are subtle and easily missed—endoscopists must carefully assess gas patterns on fluoroscopy to avoid delayed diagnosis 8, 1
  • Most clinically significant due to high morbidity and mortality 1

Type 3 (Guidewire Perforation):

  • Bile duct or pancreatic duct perforation from guidewire manipulation 2
  • Usually recognized during the procedure 2
  • Most can be managed medically with minimal morbidity 2

Type 4 (Unknown/Retroperitoneal):

  • Location cannot be determined but retroperitoneal air/fluid present 2

Risk Factors for Perforation

Patient-Related Factors:

  • Advanced age (>80 years increases mortality risk 3.8-fold after perforation occurs) 6
  • Sphincter of Oddi dysfunction as indication 1, 4
  • Non-dilated bile duct 1
  • Surgically altered anatomy (Billroth II, Roux-en-Y) 8, 1
  • Presence of duodenal diverticula 5

Procedure-Related Factors:

  • Pre-cut sphincterotomy is a major risk factor for perforation 1, 2
  • Sphincterotomy in the pancreatic duct (increases mortality risk 2.8-fold) 6
  • Access papillotomy 1
  • Longer procedure duration 1
  • Ampullectomy 8

Endoscopist/Center Factors:

  • Lower-volume centers have higher mortality after perforation, particularly with pancreatic duct sphincterotomy (45% vs 14% at high-volume centers) 6

Identification of Suspected Perforation

During the Procedure:

  • Sudden bleeding, lumen deflation, difficulty maintaining insufflation (Type 1) 1
  • Carefully assess fluoroscopy for abnormal gas patterns, particularly retroperitoneal air (Type 2) 8, 1
  • Visualization of contrast extravasation 2

Post-Procedure Clinical Signs:

  • Severe abdominal pain out of proportion to typical post-ERCP discomfort 3
  • Fever, tachycardia, peritoneal signs 3
  • Subcutaneous emphysema 3

Diagnostic Imaging:

  • Obtain contrast-enhanced CT scan immediately if perforation is suspected—this is the gold standard 7
  • Look for retroperitoneal air or fluid, duodenal wall defect, free intraperitoneal air 7, 2
  • Retroperitoneal fluid collections on CT are associated with poor outcomes and often require surgery 2

Acute Management Algorithm

Immediate Actions (All Perforations):

  • Keep patient NPO 8, 7
  • Initiate IV fluids 8, 7
  • Start broad-spectrum antibiotics covering gram-negative and anaerobic organisms 8, 7
  • Obtain urgent surgical consultation (even if endoscopic repair attempted) 8, 1
  • Place nasogastric tube (with some exceptions) 8
  • Admit for observation 8

Type-Specific Management:

Type 1 (Large Duodenal Perforation >3 cm):

  • Urgent surgical consultation while assessing feasibility of endoscopic closure 8
  • Most require surgical intervention unless early endoscopic closure successful 1

Type 2 (Periampullary/Retroperitoneal):

  • If suspected, obtain CT scan immediately—delayed recognition dramatically increases mortality 1, 7
  • Conservative management may be attempted if diagnosed early and patient stable 2, 5
  • Surgery indicated if: retroperitoneal fluid collections, clinical deterioration, or failure of conservative therapy within 24-48 hours 2, 5

Type 3 (Guidewire Perforation):

  • Most can be managed medically with antibiotics, NPO, IV fluids 2
  • Surgery rarely required 2

Endoscopic Closure Techniques (if feasible):

  • Perforations <2 cm: through-the-scope clips (TTSCs) or over-the-scope clips (OTSCs) 8
  • Perforations >2 cm: endoscopic suturing or combination of TTSCs and endoloop 8

During Endoscopic Management:

  • Aspirate liquids and change patient position to bring perforation to non-dependent location 8
  • Minimize CO2 insufflation to avoid compartment syndrome 8

Conservative Management Success Criteria:

  • 75% of leaks can be managed medically 4
  • Nonoperative management highly successful (85-90%) in carefully selected patients with early recognition 5
  • Failure indicators requiring surgery: clinical deterioration, persistent fever, worsening peritonitis, retroperitoneal fluid collections 2, 5

Before Resuming Oral Intake:

  • Obtain water-soluble contrast study to confirm absence of continuing leak 8

Risk Minimization Strategies

Pre-Procedure:

  • Thorough informed consent discussion including perforation risks, especially for high-risk procedures 8
  • Identify high-risk patients (altered anatomy, SOD, non-dilated ducts) 1
  • Consider referral to high-volume centers for complex cases 6

During Procedure:

  • Use CO2 for insufflation in all ERCPs—this is strongly encouraged for all endoscopic procedures with perforation risk 8
  • Perform procedures gently, avoiding excessive force 3
  • Be particularly cautious with pre-cut sphincterotomy 2
  • Recognize that ERCP in surgically altered anatomy carries increased perforation risk 8

Post-Procedure:

  • Maintain high index of suspicion for perforation 3
  • Do not delay imaging if perforation suspected—every hour counts 1, 7, 2

Critical Pitfalls to Avoid

  • Never dismiss subtle signs of Type 2 periampullary perforation—these are easily missed and have the highest mortality 8, 1
  • Never delay diagnosis—mortality increases dramatically after 6 hours 1, 7, 2
  • Never attempt prolonged conservative management in patients with retroperitoneal fluid collections or clinical deterioration—early aggressive surgery improves outcomes 2
  • Never underestimate perforation risk in patients with malignancy (11.2-fold increased mortality risk) 6

References

Guideline

Post-ERCP Perforation Classification and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Management of perforation after endoscopic retrograde cholangiopancreatography (ERCP): a population-based review.

HPB : the official journal of the International Hepato Pancreato Biliary Association, 2006

Guideline

Post-ERCP Complication Evaluation and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.